Target intelligence / Profile preview

Systemic inorganic phosphate pool (Pi) (Pi)

Target
Pi
Molecular classification
Inorganic ion, Metabolite, Electrolyte
01

Overview

The systemic inorganic phosphate pool refers to the total amount of free phosphate ions circulating in the extracellular fluid, primarily measured as serum phosphorus. It plays a critical role in skeletal mineralization, cellular energy transfer via adenosine triphosphate (ATP), and intracellular signaling through phosphorylation (StatPearls, 2023). Homeostasis is tightly regulated by the kidneys, intestines, and bone, under the control of hormones like parathyroid hormone (PTH), 1,25-dihydroxyvitamin D, and fibroblast growth factor 23 (FGF23) (NIH, 2022). Dysregulation leads to conditions such as hyperphosphatemia, common in chronic kidney disease (CKD), which is associated with cardiovascular calcification and increased mortality (Kidney International, 2017). Therapeutic interventions aim to modulate this pool through intestinal phosphate binders that sequester dietary phosphate, inhibitors of sodium-hydrogen exchangers (NHE3) that reduce paracellular absorption, or biologics targeting regulatory hormones to adjust renal handling (Journal of the American Society of Nephrology, 2021). Conversely, in rare genetic disorders like X-linked hypophosphatemia, the pool is pathologically depleted, requiring replacement therapy or inhibition of FGF23 to restore normal bone health (Nature Reviews Nephrology, 2019).

Other names
Serum phosphorusPlasma inorganic phosphateExtracellular phosphate poolSerum Pi
02

Mechanism of action

Reduction of intestinal phosphate absorption via chemical binding or transporter inhibition, and modulation of renal phosphate reabsorption through hormonal pathways.

03

Biological functions

Bone mineralizationEnergy metabolismSignal transductionAcid-base balanceCell membrane structure
04

Disease associations

Chronic kidney diseaseHyperphosphatemiaHypophosphatemiaCardiovascular diseaseX-linked hypophosphatemiaTumor-induced osteomalacia
05

Safety considerations

Vascular calcificationEctopic calcificationGastrointestinal intoleranceOsteomalaciaSecondary hyperparathyroidism
06

Interacting drugs

Sevelamer

7 more in the full profile.

07

Biomarkers

Serum phosphorus levelFibroblast growth factor 23 (FGF23)Parathyroid hormone (PTH)1,25-dihydroxyvitamin D

Beyond the preview

Go deeper on Systemic inorganic phosphate pool (Pi) (Pi).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Systemic inorganic phosphate pool (Pi) (Pi).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call